114 Results
Provide Feedback to Help NIH Evaluate Postdoctoral Research Training
Funding News Edition: March 1, 2023
Share your thoughts on the roles and responsibilities of academic postdocs, including challenges in recruitment, retention, and quality of life of postdoctoral trainees.
Reviewing NIAID’s Application and Award Counts for FY 2022
Funding News Edition: February 15, 2023
We share the number of R01-equivalent and R21 applications that NIAID received in the previous fiscal year (FY) as well as how many awards NIAID made in turn.
Administrative Supplement Supports Research Testing on Gender Measurement
Funding News Edition: February 15, 2023
The health conditions of interest to NIAID impact the health of sexual minority and majority populations, and the Institute endorses meaningful sexual orientation and gender identity measurement in research, clinical care, and administrative settings.
Summary of January 2023 Advisory Council Meeting
Funding News Edition: February 15, 2023
NIAID Acting Director Dr. Hugh Auchincloss provided updates on HIV/AIDS, malaria, Ebola, a promising Marburg vaccine, universal flu vaccine efforts, non-viral asthma attacks, monoclonal antibodies to target Epstein-Barr virus, and human antibody response to vaccinations.
Four Research Areas Comprise NIAID’s 2023 Omnibus Contract Solicitation
Funding News Edition: February 1, 2023
Successful offerors will help advance the research and development of promising candidate vaccines, therapeutics, and diagnostics for biodefense, emerging infectious diseases, and pandemic preparedness.
December’s ACD Meeting—Featuring Bill Gates and Dr. Anthony Fauci
Funding News Edition: February 1, 2023
NIH’s Advisory Committee to the Director (ACD) provides recommendations on program development, resource allocation, NIH administrative regulation, and other aspects of NIH policy.
Provide Input on Clinical Research Infrastructure and Emergency Clinical Trials
Funding News Edition: December 7, 2022
Recognizing lessons learned during the COVID-19 pandemic, a new request for information solicits feedback on how to strengthen the capacity of clinical trial infrastructure and emergency trials.
Apply to Integrated Preclinical/Clinical AIDS Vaccine Development Program
Funding News Edition: November 16, 2022
NIAID's initiative will fund a multidisciplinary consortium with expertise in vaccinology, animal models, molecular biology, cell biology, immunology, manufacturing, and adjuvant biology.
“In my application, should I explain our lab’s contingency plans for the COVID-19 pandemic?”
Funding News Edition: November 16, 2022
A Summary of September’s Advisory Council Meeting
Funding News Edition: October 5, 2022
NIAID Director Dr. Anthony Fauci said, "It has been an enormous pleasure and privilege of my job to have worked with the many extraordinarily intelligent and talented individuals who have served Council over the years.”
Novel R01 Seeks New and “At-Risk” Investigators from Diverse Backgrounds
Funding News Edition: October 5, 2022
Through this new initiative, eligible individuals are invited to submit investigator-initiated research project grant applications within the scope of NIAID's scientific areas of focus.
Administrative Supplements for Women’s Health Research in U3 Populations
Funding News Edition: October 5, 2022
The Notice of Special Interest encourages rigorous interdisciplinary research on the complex intersection of women’s health, sex and gender, and social determinants of health.
Pandemic Exception Ends for Semiannual Inspection of Animal Facilities
Funding News Edition: September 21, 2022
Begining October 1, 2022, all Assured institutions, including those with expiring waivers, must conduct semiannual animal facility inspections as scheduled and required by Public Health Service policy.
“What is NIH’s rule for late applications due to inclement weather?”
Funding News Edition: August 3, 2022
Recapping June’s Advisory Council Meeting
Funding News Edition: July 7, 2022
At the 201st meeting of NIAID’s Advisory Council, NIAID Director Dr. Anthony Fauci gave remarks on NIAID’s budget, outreach activities, scientific priorities, and research outcomes.
June 2022 ACD Meeting—ARPA-H, COVID-19, UNITE, and Data Sharing
Funding News Edition: July 7, 2022
NIH’s Advisory Committee to the Director (ACD) provides recommendations on program development, resource allocation, NIH administrative regulation, and other aspects of NIH policy.
Reference NIH’s Biomedical Research and Development Price Index
Funding News Edition: June 1, 2022
In general terms, the Biomedical Research and Development Price Index indicates how much money is needed to purchase the same amount of biomedical research as the year before.
COVID-19 Exception—Post-Submission Materials for January 2023 Council Rounds
Funding News Edition: May 18, 2022
An exception to allow applicants to send one page with preliminary data as post-submission materials will remain in effect for applications submitted for the January 2023 Council rounds.
Comment on the Link Between Women’s Health and the COVID-19 Pandemic
Funding News Edition: April 20, 2022
Comment on research gaps, clinical practice needs, and research priorities at the intersection of women’s health concerns and SARS-CoV-2 infection, COVID-19 illness, and post-acute sequelae of SARS-CoV-2 infection.
NIH and Tribal Nations—Commitment and Collaboration
Funding News Edition: April 6, 2022
Regular, meaningful engagement with Tribal partners helps NIH ensure American Indians and Alaska Natives are well-represented in research and benefit from its outcomes.
A Special Thank You to AViDD Peer Reviewers
Funding News Edition: April 6, 2022
Reviewers committed unusually high levels of effort in a short time to help NIAID identify and fund key research on innovative antiviral drug development targeting coronaviruses and other select RNA viruses.
Director of NIAID’s Vaccine Research Center Announces Retirement
Funding News Edition: March 16, 2022
Dr. John Mascola provided leadership for scientific and clinical research activities and developed vaccine research programs for priority diseases, including HIV, influenza, Ebola/Marburg, malaria, and COVID-19.
Research on COVID-19 Testing Among Underserved and Vulnerable Populations
Funding News Edition: March 16, 2022
Help address the urgent need for social, ethical, and behavioral implications research to understand and reduce barriers to and disparities in COVID-19 testing among underserved and vulnerable populations.
Thank You to 2021 NIAID Peer Review and Committee Volunteers
Funding News Edition: March 2, 2022
Our thanks to all who volunteer to serve on a peer review group or advisory committee; your time, effort, and contributions are critically important to help NIAID fund the best science.
Peruse NIAID’s New Pandemic Preparedness Plan
Funding News Edition: March 2, 2022
Selecting representative viruses from each virus family offers a viable pathway to gain knowledge as well as develop and test candidate countermeasures that may apply to part or all of a particular virus family.